Movano Health Launches EvieAI Virtual Wellness Assistant
- Newest Evie Ring feature is the first medical journal trained AI companion in a wearable PLEASANTON, Calif. , Jan. 8, 2025 /PRNewswire/ -- Movano Health (Nasdaq: MOVE ) today announced the latest enhancement to its Evie smart ring for women with the beta release of EvieAI, the first wearable-based virtual wellness assistant trained exclusively with data from medical journals.
- 01/08/2025
|
Transforming Travel: AirAsia MOVE Partners with Antom for Seamless Payment Solutions
- KUALA LUMPUR, Malaysia--(BUSINESS WIRE)--AirAsia MOVE (MOVE), Asean's leading travel booking app and the OTA (online travel agency) platform business of Capital A has signed a partnership agreement with Ant International's Antom as part of its continuous efforts to transform travel, including seamless payment experiences on the app. Under the agreement, AirAsia MOVE will work closely with Antom, Ant International's merchant payment and digitisation services provider, and 2C2P, a full-suite glob.
- 01/07/2025
|
Movano Health Welcomes Dr. Shaheen Wirk to its Board of Directors
- PLEASANTON, Calif. , Jan. 2, 2025 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced the expansion of its board of directors with the addition of Dr. Shaheen Wirk, a leader in healthcare dedicated investment with a track record of success in medicine, partnerships, and research.
- 01/02/2025
|
ERA REAL ESTATE LAUNCHES "MOVE UP" CAMPAIGN
- After strategic reshaping of its leadership team and service offerings, the brand shows why "It's time to move up" to ERA MADISON, N.J. , Dec. 13, 2024 /PRNewswire/ -- ERA Real Estate, a global franchising leader within the Anywhere Real Estate Inc. (NYSE: HOUS) portfolio of brands, has launched a new marketing campaign, "It's time to move up," to reinforce the ERA® brand's promise to both agents and consumers.
- 12/13/2024
|
Movano Health Receives FDA Clearance for EvieMED Ring
- Company's first 510(k) clearance unlocks a TAM of $40 billion in healthcare B2B opportunities PLEASANTON, Calif. , Dec. 2, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the pulse oximeter in its EvieMED Ring.
- 12/02/2024
|
Movano Inc. (MOVE) Q3 2024 Earnings Call Transcript
- Movano Inc. (NASDAQ:MOVE ) Q3 2024 Earnings Conference Call November 14, 2024 5:00 PM ET Company Participants J. Cogan - CFO John Mastrototaro - CEO Tyla Bucher - Chief Marketing Officer Michael Soule - Chief Commercial Officer Conference Call Participants Bruce Jackson - The Benchmark Company Operator Ladies and gentlemen, greetings, and welcome to the Movano Health Third Quarter Earnings Conference Call.
- 11/14/2024
|
Movano Health Reports Q3 2024 Financial Results and Provides Business Update
- Highlights successful Evie Ring back-in-stock execution Updates status of EvieMED 510(k) application review Focuses on launch of EvieMED and securing B2B opportunities Conference Call at 2:00 PM PT/ 5:00 PM ET Today PLEASANTON, Calif. , Nov. 14, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, reported third quarter 2024 results and provided a business update.
- 11/14/2024
|
Movano Health Announces Completion of Clinical Study with Cuffless RF Blood Pressure Device
- New hardware boasts significant improvements to reduce noise and generate higher fidelity signals PLEASANTON, Calif. , Nov. 7, 2024 /PRNewswire/ -- Movano Health Inc. (Nasdaq: MOVE) announced today that it has tested its newly developed blood pressure wrist wearable as part of its November 5 th and 6th hypoxia clinical trial that took place at the University of California, San Francisco.
- 11/07/2024
|
Movano Health to Report Third Quarter 2024 Financial Results on Thursday November 14, 2024
- Conference Call at 2:00 PM PT/ 5:00 PM ET PLEASANTON, Calif. , Nov. 6, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced that it will report third quarter 2024 financial and operating results on Thursday November 14, 2024, after the market close.
- 11/06/2024
|
Movano Health Provides Update on Investigation to Expose Apparent Stock Manipulation Following Reverse Stock Split
- Company Continues to Work with Securities Regulators, Legal Advisors and Other Partners to Protect Interests of Shareholders PLEASANTON, Calif. , Nov. 4, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE ) (the "Company") provided an update on an investigation to expose apparent manipulation in trading of the Company's common shares, following the recent announcement of a shareholder approved reverse stock split.
- 11/04/2024
|
Movano Health Submits Response to FDA as Part of Final Review Phase for EvieMED
- Company remains optimistic on the potential for this pioneering healthcare solution PLEASANTON, Calif. , Nov. 4, 2024 /PRNewswire/ -- Movano Health (NASDAQ: MOVE ) announced today that it has submitted a complete response package to the FDA as part of the final phase of the Company's 510(k) application review of the EvieMED Ring.
- 11/04/2024
|
Movano Health Opens Investigation to Expose Apparent Stock Manipulation Following Reverse Stock Split
- Company Communicating with Securities Regulators, Legal Advisors and Other Partners to Protect Interests of Shareholders PLEASANTON, Calif. , Oct. 31, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE ) (the "Company") announced today that it has opened an investigation to expose apparent manipulation in trading of the Company's common shares, following the recent announcement of a shareholder approved reverse stock split.
- 10/31/2024
|
Evie Ring Announces Brand Partnership with Lifestyle Content Creator Heidi D'Amelio
- Collaboration Will Expand Awareness of Movano's Female First Wearable to D'Amelio's 12 Million Social Media Followers PLEASANTON, Calif. , Oct. 30, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) today announced its first brand partnership with digital creator, wife, mom and entrepreneur Heidi D'Amelio.
- 10/30/2024
|
Movano Health Announces Reverse Stock Split
- Shares Expected to Begin Trading on Split-Adjusted Basis on October 29, 2024 PLEASANTON, Calif. , Oct. 25, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) announced today that it will implement a 1-for-15 reverse stock split of the issued shares of its common stock (the "Reverse Stock Split"), effective at 12:01 a.m.
- 10/25/2024
|
Movano Health Plans Response Submission to FDA Next Week as Part of EvieMED Final Review Phase
- A successful response to requests for additional information would bring the Company one step closer to introducing this pioneering healthcare product to the market PLEASANTON, Calif. , Oct. 24, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) announced today that it plans to submit updated responses next week to all clarifying questions that it recently received from the FDA as part of the final phase of the Company's 510(k) application review.
- 10/24/2024
|
Movano Health Provides Update on FDA Review of EvieMED Ring
- The Company continues to work closely with the FDA to bring this pioneering healthcare product to market PLEASANTON, Calif. , Oct. 10, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) announced today that the Company recently received additional clarifying questions from the FDA related to medical aspects of the EvieMED Ring, as part of the final phase of the Company's 510(k) application review process.
- 10/10/2024
|
Evie, Movano Health's Smart Ring for Women, is Back In Stock with Key Upgrades
- Orders Reopen with Enhancements to AI Powered Health Insights, Sleep and Heart Rate Measurements and More PLEASANTON, Calif. , Sept. 17, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) today announced the immediate availability of its Evie Ring , the first smart ring designed specifically for women.
- 09/17/2024
|
Movano Health Advances to Final Phase of FDA Review Process for EvieMED Ring
- Following the positive outcome of a recent agency meeting, the Company will continue to work closely with the FDA to bring this pioneering healthcare product to market PLEASANTON, Calif. , Sept. 3, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) announced today that a productive in-person meeting with the FDA on August 15, 2024, resulted in a positive outcome regarding the EvieMED Ring's wellness features and metrics.
- 09/03/2024
|
Movano Inc. (MOVE) Q2 2024 Earnings Call Transcript
- Movano Inc. (NASDAQ:MOVE ) Q2 2024 Earnings Conference Call August 14, 2024 5:00 PM ET Company Participants Jay Cogan - CFO John Mastrototaro - CEO Tyla Bucher - Chief Marketing Officer Michael Leabman - Founder and Chief Technology Officer Michael Soule - Chief Commercial Officer Conference Call Participants Bruce Jackson - Benchmark Company Operator Greetings and welcome to Movano Health Q2 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
- 08/14/2024
|
Movano Health Reports Q2 2024 Financial Results and Provides Business Update
- Prepares for September 17, 2024, Evie Ring back in stock date Announces brand partnership with digital creator Heidi D'Amelio Focuses on launch of EvieMED and securing B2B opportunities Conference Call at 2:00 PM PT/ 5:00 PM ET Today PLEASANTON, Calif. , Aug. 14, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, reported second quarter 2024 results and provided a business update.
- 08/14/2024
|
Movano Health to Report Second Quarter 2024 Financial Results on Wednesday August 14, 2024
- Conference Call at 2:00 PM PT/ 5:00 PM ET PLEASANTON, Calif. , Aug. 5, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced that it will report second quarter 2024 financial and operating results on Wednesday, August 14, 2024, after the market close.
- 08/05/2024
|
Movano Health Provides Progress Update on EvieMED Regulatory Filing
- Company continues to work with FDA to bring this pioneering healthcare product to market PLEASANTON, Calif. , Aug. 5, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE ) plans to meet with the FDA in mid-August, as part of the Company's ongoing process to secure a 510(k) clearance for the EvieMED Ring, a wearable designed to not only provide medical device functionality through its pulse oximetry feature, but also offer numerous wellness metrics related to sleep, activity and mood/energy/symptom logging.
- 08/05/2024
|
Movano Health Announces Dr. Fatima Rodriguez Joining July 11 Virtual Event
- Allele Capitals' Matt Hughes will moderate future forward panel on enterprise need in wearables for a variety of healthcare applications PLEASANTON, Calif. , June 28, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) announced the addition of two expert participants to its B2B: The Next Wearables Boom Virtual Event to be held on July 11 – Dr. Fatima Rodriguez and Matt Hughes.
- 06/28/2024
|
Movano Health Applies Advanced AI through Deep Learning to Deliver Improved Accuracy of Heart Rate in Motion
- Enhancements address significant clinical enterprise need in wearables for a variety of healthcare applications PLEASANTON, Calif., June 13, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE ) announced major advances in the accuracy of its heart rate in motion algorithm following the implementation of deep learning into the processing.
- 06/13/2024
|
MIT Selects Movano Health for Groundbreaking Study on Long COVID and Chronic Lyme Disease
- Pioneering partnership advances innovative health monitoring, setting the stage for future enterprise opportunities. PLEASANTON, Calif.
- 06/10/2024
|
TREASURIES-US yields drift higher in quiet trading session
- NEW YORK, May 20 (Reuters) - U.S. Treasury yields ticked higher on Monday as investors likely sold government bonds to buy new corporate debt, while Federal Reserve officials pointed to uncertainty over the central bank's ability to cut interest rates if inflation remains sticky. Investors largely expected a period of consolidation in Treasuries after softening consumer prices last month strengthened views that the Federal Reserve may be able to cut interest rates twice this year. Yields, which move inversely to prices, have mostly declined over the past few weeks on indications that the economy was slowing, partly reversing months of gains caused by fears that inflation was rebounding. Monday's yield increases were a sign the market was "trying to find a balance" after the recent bond rally, said Danny Zaid, a portfolio manager at TwentyFour Asset Management, who expects Treasuries to be less volatile over the next few weeks. The ICE BofA MOVE Index, a measure of expected volatility in U.S. Treasuries, stood at its lowest since the end of March. "It's very quiet ... I think the selling probably has more to do with new issue deals announced this morning," said Tony Farren, managing director at Mischler Financial Group, referring to a slate of new corporate bond sales announced on Monday. With no U.S. economic data releases on both Monday and Tuesday, Fed officials' remarks took center stage ahead of Wednesday's publication of minutes of the Fed's most recent policy meting, which may provide more insight on the central bank's views on the path of interest rates. Atlanta Fed President Raphael Bostic said in an interview on Monday that "it will take a while" for the Fed to be confident that inflation is on track back to the central bank's 2% goal. Fed vice chair for supervision Michael Barr struck a similar tone, saying that inflation data in the first months of this year has been disappointing, which left the central bank short of the evidence it needs to ease monetary policy. "We will need to allow our restrictive policy some further time to continue its work," Barr said. Separately, Fed Vice Chairman Phillip Jefferson said he was cautiously optimistic the central bank could continue to battle inflation while permitting the economy to grow. Traders of futures tied to the Fed's policy rate on Monday saw a total of about 42 basis points of interest rate cuts this year, down from over 50 basis points in the aftermath of data last week showing U.S. consumer price inflation cooled in April. Benchmark 10-year yields were last seen at 4.437%, nearly two basis points higher than Friday. Two-year yields, which tend to more closely reflect monetary policy expectations, were last at 4.837%, up about one basis point. (Reporting by Davide Barbuscia)
- 05/20/2024
|
TREASURIES-US yields drift higher in quiet trading session
- NEW YORK, May 20 (Reuters) - U.S. Treasury yields ticked higher on Monday as investors likely sold government bonds to buy new corporate debt, while Federal Reserve officials pointed to uncertainty over the central bank's ability to cut interest rates if inflation remains sticky. Investors largely expected a period of consolidation in Treasuries after softening consumer prices last month strengthened views that the Federal Reserve may be able to cut interest rates twice this year. Yields, which move inversely to prices, have mostly declined over the past few weeks on indications that the economy was slowing, partly reversing months of gains caused by fears that inflation was rebounding. Monday's yield increases were a sign the market was "trying to find a balance" after the recent bond rally, said Danny Zaid, a portfolio manager at TwentyFour Asset Management, who expects Treasuries to be less volatile over the next few weeks. The ICE BofA MOVE Index, a measure of expected volatility in U.S. Treasuries, stood at its lowest since the end of March. "It's very quiet ... I think the selling probably has more to do with new issue deals announced this morning," said Tony Farren, managing director at Mischler Financial Group, referring to a slate of new corporate bond sales announced on Monday. With no U.S. economic data releases on both Monday and Tuesday, Fed officials' remarks took center stage ahead of Wednesday's publication of minutes of the Fed's most recent policy meting, which may provide more insight on the central bank's views on the path of interest rates. Atlanta Fed President Raphael Bostic said in an interview on Monday that "it will take a while" for the Fed to be confident that inflation is on track back to the central bank's 2% goal. Fed vice chair for supervision Michael Barr struck a similar tone, saying that inflation data in the first months of this year has been disappointing, which left the central bank short of the evidence it needs to ease monetary policy. "We will need to allow our restrictive policy some further time to continue its work," Barr said. Separately, Fed Vice Chairman Phillip Jefferson said he was cautiously optimistic the central bank could continue to battle inflation while permitting the economy to grow. Traders of futures tied to the Fed's policy rate on Monday saw a total of about 42 basis points of interest rate cuts this year, down from over 50 basis points in the aftermath of data last week showing U.S. consumer price inflation cooled in April. Benchmark 10-year yields were last seen at 4.437%, nearly two basis points higher than Friday. Two-year yields, which tend to more closely reflect monetary policy expectations, were last at 4.837%, up about one basis point. (Reporting by Davide Barbuscia)
- 05/20/2024
|
Movano Inc. (MOVE) Q1 2024 Earnings Call Transcript
- Movano Inc. (NASDAQ:MOVE ) Q1 2024 Earnings Conference Call May 15, 2024 5:00 PM ET Company Participants John Mastrototaro - Chief Executive Officer Michael Soule - Vice President of Business Development Jeremy Cogan - Chief Financial Officer Stacy Salvi - Vice President of Products and Strategy Tyla Bucher - Chief Marketing Officer Michael Leabman - Founder and CTO Conference Call Participants Operator Greetings and welcome to the Movano Health Q1 2024 Earnings Call. At this time, all participants are in a listen-only mode.
- 05/15/2024
|
Movano Health Reports Q1 2024 Financial Results and Provides Business Update
- Submits exemplary Sp02 clinical trial results as part of FDA 510(k) clearance process Plans launch of Evie Med and focuses on B2B opportunities Plans arterial blood pressure study for June Conference Call at 2:00 PM PT/ 5:00 PM ET Today PLEASANTON, Calif. , May 15, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, reported first quarter 2024 results and provided a business update.
- 05/15/2024
|
Movano Health Submits Exemplary Sp02 Clinical Trial Results in Key Step Towards FDA 510(k) Clearance Decision
- Unlocking business-to-business opportunities with Evie Med, Movano Health's ring pulse oximeter, remains a key priority for the Company. PLEASANTON, Calif.
- 05/09/2024
|
Movano Health to Report First Quarter 2024 Financial Results on Wednesday May 15, 2024
- Conference Call at 2:00 PM PT/ 5:00 PM ET PLEASANTON, Calif., May 6, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced that it will report first quarter 2024 financial and operating results on Wednesday May 15, 2024, after the market close.
- 05/06/2024
|
Movano Health Closes $24 Million Private Placement
- Financing included a strategic seed investment by a tier-1 multi-billion dollar medical device company and participation from insiders including members of Movano Health's management team and board of directors PLEASANTON, Calif. , April 5, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, has closed on a $24.1 million private placement, totaling 45.3 million units, with each unit consisting of one share of the Company's common stock (or pre-funded warrant in lieu thereof) and one warrant to purchase a share of common stock, to a select group of investors that includes a tier-one multi-billion dollar medical device company, institutional and accredited investors, and members of the Company's management team and board of directors.
- 04/05/2024
|
Movano Health Reports 2023 Financial Results and Provides Business Update
- Executes $24 million funding extending cash runway Focuses on 2024 strategic pathway to FDA clearances driving B2B opportunities Plans launch of Evie Med Conference Call at 2:00 PM PT/ 5:00 PM ET Today PLEASANTON, Calif. , April 4, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, reported fourth quarter and year end 2023 results and provided a business update.
- 04/04/2024
|
Movano Health Announces $24 Million Private Placement
- Financing included a strategic seed investment by a tier-1 multi-billion dollar medical device company and participation from members of Movano Health's management team and board of directors Hosting conference call on April 4, 2024 at 2:00 PM PT/5:00 PM ET PLEASANTON, Calif. , April 2, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, today has agreed to sell approximately 45 million units in a $24 million private placement, with each unit consisting of one share of the Company's common stock (or pre-funded warrant in lieu thereof) and one warrant to purchase a share of common stock, to a select group of investors that includes a tier-one multi-billion dollar medical device company, institutional and accredited investors, and members of the Company's management team and board of directors.
- 04/02/2024
|
Movano Health Secures Strategic Investment from Tier-One Multi-Billion Dollar Medical Device Company
- The seed investment and agreement underscores Movano Health's multi-analyte and proprietary mmWave radio frequency technology PLEASANTON, Calif. , April 2, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, secured a strategic investment from a tier-one multi-billion dollar medical device company and signed an agreement to explore future collaborations relating to development and commercialization.
- 04/02/2024
|
Movano Health to Report Fourth Quarter 2023 Financial Results on Thursday, April 4, 2024
- Conference Call at 2:00 PM PT/ 5:00 PM ET PLEASANTON, Calif. , April 2, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced that it will report fourth quarter 2023 financial and operating results on Thursday, April 4, 2024, after the market close.
- 04/02/2024
|
Movano Health Announces Evie Rings Now Shipping
- PLEASANTON, Calif. , Jan. 22, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, announced that its female first wearable, the Evie Ring, will begin shipping today.
- 01/22/2024
|
Movano Health and ams OSRAM Collaborate to Deliver Accurate Lifestyle Monitoring Solutions for Women
- LAS VEGAS, Jan. 9, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, and ams OSRAM, a leader in technology for biometric monitoring, have collaborated to include ams OSRAMs PPG sensor solution in the Evie Ring, Movano Health's smart ring designed specifically for women. With the goal to bring high-quality data to the forefront of consumer health devices, Movano Health´s female-first wearable, the Evie Ring, is a personalized solution designed specifically for women that provides medical-grade data measurement of critical vitals for an on-demand understanding of overall health.
- 01/09/2024
|
Evie, the First Women-Focused Health Ring, Takes 'Smart' to a New Level
- Movano Health's 2024 CES Innovation Honoree Ships This Month LAS VEGAS , Jan. 8, 2024 /PRNewswire/ -- The Evie Ring from Movano Health (Nasdaq: MOVE), the market's first women-focused smart ring, is redefining the wearable category with a unique band design, female-specific data interpretation, and AI-based trend analysis that goes beyond raw activity scores to improve users' ability to understand and manage their health. Evie earned a 2024 CES Innovation Honoree Award, begins shipping this month, and was showcased over the weekend at CES Unveiled in Las Vegas.
- 01/08/2024
|
Movano Health Announces HSA/FSA Eligibility for its Women First Wearable, The Evie Ring
- PLEASANTON, Calif. , Dec. 18, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced that its female first wearable, the Evie Ring, is now eligible for HSA/FSA fund reimbursement.
- 12/18/2023
|
Movano Health Announces Blood Pressure Partnership Forum Following Significant Response to Groundbreaking Accuracy Achievement
- PLEASANTON, Calif. , Dec. 12, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced that following the successful results of its recent blood pressure clinical trial it will be holding in person demonstrations of live waveforms at both the 2024 CES Show in Las Vegas January 8-11, 2024 and in conjunction with the JP Morgan Healthcare Conference in San Francisco January 9-10, 2024.
- 12/12/2023
|
Movano Health Announces Over $1M Black Friday Holiday Launch Results for the Evie Ring as well as Cuffless Blood Pressure Milestone Achievement
- PLEASANTON, Calif. , Nov. 29, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announces the successful ecommerce launch of the Evie Ring, the innovative smart ring designed for women, which has exceeded the Company's commercial sales goals driving over $1 million in orders through the Thanksgiving Holiday.
- 11/29/2023
|
Evie, the Smart Ring for Women from Movano Health, Available for Order Today
- Unique Design, Women-Focused Metrics and Cross-Data Trend Analysis Set a New Bar for Wearables PLEASANTON, Calif. , Nov. 20, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) begins taking orders for the Evie Ring, the smart ring designed specifically for women, today at 12 pm EST.
- 11/20/2023
|
Movano Health Announces Closing of $4.1 Million Public Offering Including Full Exercise of Over-Allotment Option
- PLEASANTON, Calif. , Nov. 17, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) ("Movano Health" or the "Company"), a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices and makers of the Evie Ring, today announced the closing of its $4.1 million underwritten public offering of 4,870,600 shares of its common stock, including 635,296 shares of its common stock issued pursuant to the full exercise by the underwriter of its over-allotment option.
- 11/17/2023
|
Movano Inc. (MOVE) Q3 2023 Earnings Call Transcript
- Movano Inc. (NASDAQ:MOVE ) Q3 2023 Earnings Conference Call November 15, 2023 11:30 AM ET Company Participants Jay Cogan - Chief Financial Officer John Mastrototaro - Chief Executive Officer Tyler Bucher - Chief Marketing Officer Michael Leabman - Founder and Chief Technology Officer Stacy Salvi - Vice President, Product and Strategy Operator Hello and welcome to Movano Health Third Quarter 2023 Earnings Call. I'd like to remind everyone that this call is being recorded and a replay of the call will be available on Movano Health's website, ir.movano.com.
- 11/15/2023
|
Movano Health Provides Business Update and Reports Third Quarter 2023 Financial Results
- Conference call begins at 8:30 a.m. Pacific time today PLEASANTON, Calif.
- 11/15/2023
|
Movano Health Prices $3.6 Million Public Offering
- PLEASANTON, Calif. , Nov. 15, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) ("Movano Health" or the "Company"), a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices and makers of the Evie Ring, today announced that it has priced a $3.6 million underwritten public offering of 4,235,304 shares of its common stock.
- 11/15/2023
|
Movano Inc. to Report Third Quarter 2023 Financial Results on Wednesday, November 15, 2023
- Reschedules Q3 results conference call to 11:30 am EST on November 15, 2023 PLEASANTON, Calif. , Nov. 14, 2023 /PRNewswire/ -- Movano Inc. (NASDAQ:MOVE) dba Movano Health, a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices and makers of the Evie Ring , today announced that, in light of the Company's recently announced proposed common stock offering, Movano Health has issued its Form 10-Q for the third quarter of 2023 and will report third quarter 2023 financial and operating results on Wednesday, November 15, 2023, before the equity markets open.
- 11/14/2023
|
Movano Inc. to Report Third Quarter 2023 Financial Results Tuesday, November 14, 2023
- PLEASANTON, Calif. , Nov. 3, 2023 /PRNewswire/ -- Movano Inc. (NASDAQ:MOVE) dba Movano Health, a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices and makers of the Evie Ring, today announced that it will report third quarter 2023 financial and operating results on Tuesday, November 14, 2023.
- 11/03/2023
|
Movano Inc. (MOVE) Q2 2023 Earnings Call Transcript
- Movano Inc. (NASDAQ:MOVE ) Q2 2023 Earnings Conference Call August 14, 2023 4:30 PM ET Company Participants Jeremy Cogan - CFO & Secretary John Mastrototaro - CEO, President & Director Michael Aaron Leabman - Founder, CTO & Director Tyla Bucher - Chief Marketing Officer Conference Call Participants Marie Thibault - B. Riley Operator Greetings and welcome to the Movano Second Quarter 2023 Earnings Call.
- 08/15/2023
|
Movano Inc. to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023
- PLEASANTON, Calif. , Aug. 8, 2023 /PRNewswire/ -- Movano Inc. (NASDAQ:MOVE) dba Movano Health, a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices and makers of the Evie Ring, today announced that it will report second quarter 2023 financial and operating results on Monday, August 14, 2023.
- 08/08/2023
|
Movano Inc. (MOVE) Q1 2023 Earnings Call Transcript
- Movano Inc. (NASDAQ:MOVE ) Q1 2023 Earnings Conference Call May 15, 2023 12:00 PM ET Company Participants J. Cogan – Chief Financial Officer John Mastrototaro – Chief Executive Officer Tyla Bucher – Chief Marketing Officer Stacy Salvi – Vice President of Strategy Michael Leabman – Founder and Chief Technology Officer Conference Call Participants Operator Greetings, and welcome to Movano's First Quarter 2023 Earnings Call.
- 05/15/2023
|
Movano Inc. (MOVE) Q4 2022 Earnings Call Transcript
- Movano Inc. (NASDAQ:MOVE ) Q4 2022 Earnings Conference Call March 20, 2023 12:00 PM ET Company Participants J. Cogan - Chief Financial Officer John Mastrototaro - Chief Executive Officer Tyla Bucher - Chief Marketing Officer Michael Leabman - Founder and Chief Technology Officer Stacy Salvi - Vice President of Strategy Conference Call Participants Bruce Jackson - The Benchmark Company Operator Hello, and welcome to Movano Health Fourth Quarter 2022 Earnings Call.
- 03/20/2023
|
Movano's new smart ring is focused on women's health
- Movano's getting a week's jump on what might well prove a banner CES for the smart ring. Today the Bay Area-based firm debuted Evie, a smart ring focused on women's health set to hit the market later next year.
- 12/28/2022
|
Movano Inc. (MOVE) Q3 2022 Earnings Call Transcript
- Movano Inc. (NASDAQ:MOVE ) Q3 2022 Earnings Conference Call November 14, 2022 5:00 PM ET Company Participants J. Cogan – Chief Financial Officer John Mastrototaro – Chief Executive Officer Stacy Salvi – Vice President of Strategy Conference Call Participants Marie Thibault – BTIG Operator Greetings.
- 11/14/2022
|
Movano Inc. (MOVE) CEO John Mastrototaro on Q2 2022 Results - Earnings Call Transcript
- Movano Inc. (NASDAQ:MOVE ) Q2 2022 Earnings Conference Call August 17, 2022 5:00 PM ET Company Participants John Mastrototaro - CEO J. Cogan - CFO Michael Leabman - CTO Conference Call Participants Operator Greeting and welcome to the Movano Second Quarter 2022 Earnings Call.
- 08/15/2022
|
Movano Inc. (MOVE) CEO John Mastrototaro on Q1 2022 Results - Earnings Call Transcript
- Movano Inc. (NASDAQ:MOVE ) Q1 2022 Earnings Conference Call May 12, 2022 5:00 PM ET Company Participants John Mastrototaro - CEO J. Cogan - CFO Michael Leabman - CTO Conference Call Participants Michael Diana - Maxim Group Mark Argento - Lake Street Operator J.
- 05/15/2022
|
Executives Buy Around $1M Of 4 Penny Stocks
- The ISM services PMI rose to 58.3 in March from 56.5 in the previous month. Investors, meanwhile, focused on some notable insider trades.
- 04/05/2022
|
Movano Inc. (MOVE) CEO John Mastrototaro on Q4 2021 Results - Earnings Call Transcript
- Movano Inc. (MOVE) CEO John Mastrototaro on Q4 2021 Results - Earnings Call Transcript
- 03/24/2022
|
Movano to Report Fourth Quarter 2021 Financial Results on Thursday, March 24, 2022
- PLEASANTON, Calif., March 10, 2022 /PRNewswire/ -- Movano Inc. (NASDAQ:MOVE), a health technology company designing devices that inspire and empower you to live a healthier, happier life, today announced that it will report fourth quarter 2021 financial and operating results on Thursday, March 24, 2022.
- 03/10/2022
|
Movano targets an H2 2022 launch for its fitness ring
- My first in-person experience with a fitness ring was back at CES 2017. Four years later, one wonders if they might be having a moment at next week's show — in-person or no.
- 12/27/2021
|
Movano Inc. (MOVE) CEO John Mastrototaro on Q3 2021 Results - Earnings Call Transcript
- Movano Inc. (MOVE) CEO John Mastrototaro on Q3 2021 Results - Earnings Call Transcript
- 11/11/2021
|
Clean Power Capital Graduates Listing to the NEO Exchange
- TORONTO--(BUSINESS WIRE)---- $MOVE #NEOExchange--Clean Power Capital Corp. (NEO:MOVE), previously listed on the Canadian Securities Exchange, has graduated to the NEO Exchange.
- 04/26/2021
|
